{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:42:00Z","timestamp":1790293320413,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000166","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["Grant 5T32MH073124-10"],"award-info":[{"award-number":["Grant 5T32MH073124-10"]}],"id":[{"id":"10.13039\/100000166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT","award":["U54 HD079125"],"award-info":[{"award-number":["U54 HD079125"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00213-015-4115-7","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:06:09Z","timestamp":1446509169000},"page":"309-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism"],"prefix":"10.1007","volume":"233","author":[{"given":"Tatiana M.","family":"Kazdoba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zolkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rogawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline N.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"4115_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fgene.2014.00355","volume":"5","author":"L Abbeduto","year":"2014","unstructured":"Abbeduto L, McDuffie A, Thurman AJ (2014) The fragile X syndrome-autism comorbidity: what do we really know? Front Genet 5:355","journal-title":"Front Genet"},{"key":"4115_CR2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Washington","edition":"5"},{"key":"4115_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1023\/A:1026048027397","volume":"28","author":"DB Bailey Jr","year":"1998","unstructured":"Bailey DB Jr, Mesibov GB, Hatton DD, Clark RD, Roberts JE, Mayhew L (1998) Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord 28:499\u2013508","journal-title":"J Autism Dev Disord"},{"key":"4115_CR4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3565(24)37308-2","volume":"284","author":"M Beekman","year":"1998","unstructured":"Beekman M, Ungard JT, Gasior M, Carter RB, Dijkstra D, Goldberg SR, Witkin JM (1998) Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone. J Pharmacol Exp Ther 284:868\u2013877","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrn1703","volume":"6","author":"D Belelli","year":"2005","unstructured":"Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABAA receptor. Nat Rev Neurosci 6:565\u2013575","journal-title":"Nat Rev Neurosci"},{"key":"4115_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0920-1211(90)90036-U","volume":"5","author":"EH Bertram","year":"1990","unstructured":"Bertram EH, Lothman EW (1990) NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants. Epilepsy Res 5:177\u2013184","journal-title":"Epilepsy Res"},{"key":"4115_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0006-8993(91)90761-J","volume":"561","author":"D Bitran","year":"1991","unstructured":"Bitran D, Hilvers RJ, Kellogg CK (1991) Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561:157\u2013161","journal-title":"Brain Res"},{"key":"4115_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neubiorev.2011.06.008","volume":"36","author":"DC Blanchard","year":"2012","unstructured":"Blanchard DC, Defensor EB, Meyza KZ, Pobbe RL, Pearson BL, Bolivar VJ, Blanchard RJ (2012) BTBR T+tf\/J mice: autism-relevant behaviors and reduced fractone-associated heparan sulfate. Neurosci Biobehav Rev 36:285\u2013296","journal-title":"Neurosci Biobehav Rev"},{"key":"4115_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbr.2006.09.007","volume":"176","author":"VJ Bolivar","year":"2007","unstructured":"Bolivar VJ, Walters SR, Phoenix JL (2007) Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav Brain Res 176:21\u201326","journal-title":"Behav Brain Res"},{"key":"4115_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/gbb.12115","volume":"13","author":"J Brielmaier","year":"2014","unstructured":"Brielmaier J, Senerth JM, Silverman JL, Matteson PG, Millonig JH, DiCicco-Bloom E, Crawley JN (2014) Chronic desipramine treatment rescues depression-related, social and cognitive deficits in engrailed-2 knockout mice. Genes Brain Behav 13:286\u2013298","journal-title":"Genes Brain Behav"},{"key":"4115_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainresbull.2013.05.003","volume":"96","author":"JA Burket","year":"2013","unstructured":"Burket JA, Benson AD, Tang AH, Deutsch SI (2013) D-Cycloserine improves sociability in the BTBR T+ Itpr3tf\/J mouse model of autism spectrum disorders with altered Ras\/Raf\/ERK1\/2 signaling. Brain Res Bull 96:62\u201370","journal-title":"Brain Res Bull"},{"key":"4115_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.mp.4001011","volume":"7","author":"JD Buxbaum","year":"2002","unstructured":"Buxbaum JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J, Cook EH Jr, Fang Y, Song CY, Vitale R (2002) Association between a GABRB3 polymorphism and autism. Mol Psychiatry 7:311\u2013316","journal-title":"Mol Psychiatry"},{"key":"4115_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0149-7634(02)00007-6","volume":"26","author":"RN Cardinal","year":"2002","unstructured":"Cardinal RN, Parkinson JA, Hall J, Everitt BJ (2002) Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26:321\u2013352","journal-title":"Neurosci Biobehav Rev"},{"key":"4115_CR14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","volume":"280","author":"RB Carter","year":"1997","unstructured":"Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, White HS, Wolf HH, Mirsadeghi S, Tahir SH, Bolger MB, Lan NC, Gee KW (1997) Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid (A) receptor. J Pharmacol Exp Ther 280:1284\u20131295","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0091-3057(95)00163-Q","volume":"52","author":"JC Cole","year":"1995","unstructured":"Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute\/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473\u2013478","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","volume":"9","author":"JN Crawley","year":"1985","unstructured":"Crawley JN (1985) Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9:37\u201344","journal-title":"Neurosci Biobehav Rev"},{"key":"4115_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0361-9230(82)90087-9","volume":"8","author":"JN Crawley","year":"1982","unstructured":"Crawley JN, Davis LG (1982) Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 8:609\u2013612","journal-title":"Brain Res Bull"},{"key":"4115_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0091-3057(98)00220-2","volume":"62","author":"A Dalvi","year":"1999","unstructured":"Dalvi A, Rodgers RJ (1999) Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacol Biochem Behav 62:727\u2013734","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000328161","volume":"65","author":"S Darbra","year":"2012","unstructured":"Darbra S, Pallares M (2012) Effects of early postnatal allopregnanolone administration on elevated plus maze anxiety scores in adult male Wistar rats. Neuropsychobiology 65:20\u201327","journal-title":"Neuropsychobiology"},{"key":"4115_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/epi.12121","volume":"54","author":"MG Distler","year":"2013","unstructured":"Distler MG, Gorfinkle N, Papale LA, Wuenschell GE, Termini J, Escayg A, Winawer MR, Palmer AA (2013) Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility. Epilepsia 54:649\u2013657","journal-title":"Epilepsia"},{"key":"4115_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2004.11.001","volume":"29","author":"BO Dubrovsky","year":"2005","unstructured":"Dubrovsky BO (2005) Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuro-Psychopharmacol Biol Psychiatry 29:169\u2013192","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4115_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res Off J Int Soc Autism Res 5:160\u2013179","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"4115_CR23","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.neuropharm.2012.08.012","volume":"63","author":"J Evans","year":"2012","unstructured":"Evans J, Sun Y, McGregor A, Connor B (2012) Allopregnanolone regulates neurogenesis and depressive\/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 63:1315\u20131326","journal-title":"Neuropharmacology"},{"key":"4115_CR24","unstructured":"File SE, Lippa AS, Beer B, Lippa MT (2004) Animal tests of anxiety. Current protocols in neuroscience\/editorial board, Jacqueline N Crawley [et al.] Chapter 8: Unit 8 3"},{"key":"4115_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ntt.2014.10.008","volume":"47","author":"BM Flannery","year":"2015","unstructured":"Flannery BM, Silverman JL, Bruun DA, Puhger KR, McCoy MR, Hammock BD, Crawley JN, Lein PJ (2015) Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine. Neurotoxicol Teratol 47:36\u201345","journal-title":"Neurotoxicol Teratol"},{"key":"4115_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1021424108213","volume":"28","author":"KM Garrett","year":"1998","unstructured":"Garrett KM, Niekrasz I, Haque D, Parker KM, Seale TW (1998) Genotypic differences between C57BL\/6 and A inbred mice in anxiolytic and sedative actions of diazepam. Behav Genet 28:125\u2013136","journal-title":"Behav Genet"},{"key":"4115_CR27","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0028-3908(99)00190-2","volume":"39","author":"M Gasior","year":"2000","unstructured":"Gasior M, Ungard JT, Beekman M, Carter RB, Witkin JM (2000) Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate. Neuropharmacology 39:1184\u20131196","journal-title":"Neuropharmacology"},{"key":"4115_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.neuron.2014.06.033","volume":"83","author":"N Gogolla","year":"2014","unstructured":"Gogolla N, Takesian AE, Feng G, Fagiolini M, Hensch TK (2014) Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron 83:894\u2013905","journal-title":"Neuron"},{"key":"4115_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2010.07104.x","volume":"116","author":"GG Gould","year":"2011","unstructured":"Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC (2011) Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf\/J mouse social behavior. J Neurochem 116:291\u2013303","journal-title":"J Neurochem"},{"key":"4115_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s002130050038","volume":"148","author":"G Griebel","year":"2000","unstructured":"Griebel G, Belzung C, Perrault G, Sanger DJ (2000) Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology 148:164\u2013170","journal-title":"Psychopharmacology"},{"key":"4115_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ajmg.1320230128","volume":"23","author":"RJ Hagerman","year":"1986","unstructured":"Hagerman RJ, Jackson AW 3rd, Levitas A, Rimland B, Braden M (1986) An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet 23:359\u2013374","journal-title":"Am J Med Genet"},{"key":"4115_CR32","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.neuron.2014.01.016","volume":"81","author":"S Han","year":"2014","unstructured":"Han S, Tai C, Jones CJ, Scheuer T, Catterall WA (2014) Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron 81:1282\u20131289","journal-title":"Neuron"},{"key":"4115_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1352\/2008.113:427-438","volume":"113","author":"SW Harris","year":"2008","unstructured":"Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ (2008) Autism profiles of males with fragile X syndrome. Am J Ment Retard AJMR 113:427\u2013438","journal-title":"Am J Ment Retard AJMR"},{"key":"4115_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0091-3057(95)02122-1","volume":"53","author":"DR Helton","year":"1996","unstructured":"Helton DR, Berger JE, Czachura JF, Rasmussen K, Kallman MJ (1996) Central nervous system characterization of the new cholecystokininB antagonist LY288513. Pharmacol Biochem Behav 53:493\u2013502","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)37253-2","volume":"284","author":"DR Helton","year":"1998","unstructured":"Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651\u2013660","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbr.2012.01.031","volume":"229","author":"I Heulens","year":"2012","unstructured":"Heulens I, D\u2019Hulst C, Van Dam D, De Deyn PP, Kooy RF (2012) Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res 229:244\u2013249","journal-title":"Behav Brain Res"},{"key":"4115_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/hmg\/ddm014","volume":"16","author":"A Hogart","year":"2007","unstructured":"Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM (2007) 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum Mol Genet 16:691\u2013703","journal-title":"Hum Mol Genet"},{"key":"4115_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jmg.2008.061580","volume":"46","author":"A Hogart","year":"2009","unstructured":"Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, Schanen NC, LaSalle JM (2009) Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 46:86\u201393","journal-title":"J Med Genet"},{"key":"4115_CR39","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1007\/s00213-014-3494-5","volume":"231","author":"DJ Hogenkamp","year":"2014","unstructured":"Hogenkamp DJ, Tran MB, Yoshimura RF, Johnstone TB, Kanner R, Gee KW (2014) Pharmacological profile of a 17beta-heteroaryl-substituted neuroactive steroid. Psychopharmacology 231:3517\u20133524","journal-title":"Psychopharmacology"},{"key":"4115_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature05324","volume":"444","author":"AM Hosie","year":"2006","unstructured":"Hosie AM, Wilkins ME, da Silva HM, Smart TG (2006) Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444:486\u2013489","journal-title":"Nature"},{"key":"4115_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF02247441","volume":"124","author":"NJ Johnson","year":"1996","unstructured":"Johnson NJ, Rodgers RJ (1996) Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice. Psychopharmacology 124:355\u2013364","journal-title":"Psychopharmacology"},{"key":"4115_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1176\/appi.ajp.2011.10101532","volume":"168","author":"YS Kim","year":"2011","unstructured":"Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR (2011) Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 168:904\u2013912","journal-title":"Am J Psychiatry"},{"key":"4115_CR43","unstructured":"Kooy F, Heulens I, Sabanov V, Ahmed T, Popp A, Willemsen R, D'Hooge R, Baltschun D, Rooms L (2013) Hippocampal defects in the Fmr1 knockout mouse, American Society of Human Genetics"},{"key":"4115_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.wnr.0000194383.02999.c5","volume":"17","author":"K Kuraoka","year":"2006","unstructured":"Kuraoka K, Nakamura K (2006) Impacts of facial identity and type of emotion on responses of amygdala neurons. Neuroreport 17:9\u201312","journal-title":"Neuroreport"},{"key":"4115_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0361-9230(01)00569-X","volume":"55","author":"CJ LaBuda","year":"2001","unstructured":"LaBuda CJ, Fuchs PN (2001) The anxiolytic effect of acute ethanol or diazepam exposure is unaltered in mu-opioid receptor knockout mice. Brain Res Bull 55:755\u2013760","journal-title":"Brain Res Bull"},{"key":"4115_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","volume":"16","author":"JJ Lambert","year":"1995","unstructured":"Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16:295\u2013303","journal-title":"Trends Pharmacol Sci"},{"key":"4115_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","volume":"71","author":"JJ Lambert","year":"2003","unstructured":"Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA (2003) Neurosteroid modulation of GABAA receptors. Prog Neurobiol 71:67\u201380","journal-title":"Prog Neurobiol"},{"key":"4115_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0091-3057(00)00419-6","volume":"67","author":"EM Lepicard","year":"2000","unstructured":"Lepicard EM, Joubert C, Hagneau I, Perez-Diaz F, Chapouthier G (2000) Differences in anxiety-related behavior and response to diazepam in BALB\/cByJ and C57BL\/6J strains of mice. Pharmacol Biochem Behav 67:739\u2013748","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR49","first-page":"180","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180\u2013185","journal-title":"Psychopharmacology"},{"key":"4115_CR50","doi-asserted-by":"crossref","unstructured":"McDuffie A, Thurman AJ, Hagerman RJ, Abbeduto L (2014) Symptoms of autism in males with fragile X syndrome: a comparison to nonsyndromic ASD using current ADI-R scores. J Autism Dev Disord","DOI":"10.1007\/s10803-013-2013-6"},{"key":"4115_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","volume":"7","author":"HG McFarlane","year":"2008","unstructured":"McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN (2008) Autism-like behavioral phenotypes in BTBR T+tf\/J mice. Genes Brain Behav 7:152\u2013163","journal-title":"Genes Brain Behav"},{"key":"4115_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbr.2011.03.058","volume":"222","author":"L Modol","year":"2011","unstructured":"Modol L, Darbra S, Pallares M (2011) Neurosteroids infusion into the CA1 hippocampal region on exploration, anxiety-like behaviour and aversive learning. Behav Brain Res 222:223\u2013229","journal-title":"Behav Brain Res"},{"key":"4115_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.04.003","volume":"116","author":"AL Morrow","year":"2007","unstructured":"Morrow AL (2007) Recent developments in the significance and therapeutic relevance of neuroactive steroids\u2014introduction to the special issue. Pharmacol Ther 116:1\u20136","journal-title":"Pharmacol Ther"},{"key":"4115_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","volume":"176","author":"SS Moy","year":"2007","unstructured":"Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN (2007) Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 176:4\u201320","journal-title":"Behav Brain Res"},{"key":"4115_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tics.2007.08.013","volume":"11","author":"EA Murray","year":"2007","unstructured":"Murray EA (2007) The amygdala, reward and emotion. Trends Cogn Sci 11:489\u2013497","journal-title":"Trends Cogn Sci"},{"key":"4115_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/jpet.113.203331","volume":"345","author":"JC Oakley","year":"2013","unstructured":"Oakley JC, Cho AR, Cheah CS, Scheuer T, Catterall WA (2013) Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome. J Pharmacol Exp Ther 345:215\u2013224","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR57","first-page":"2311","volume":"6","author":"SM Paul","year":"1992","unstructured":"Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J Off Publ Fed Am Soc Exp Biol 6:2311\u20132322","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"4115_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.psych.56.091103.070234","volume":"57","author":"EA Phelps","year":"2006","unstructured":"Phelps EA (2006) Emotion and cognition: insights from studies of the human amygdala. Annu Rev Psychol 57:27\u201353","journal-title":"Annu Rev Psychol"},{"key":"4115_CR59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fncel.2014.00256","volume":"8","author":"G Pinna","year":"2014","unstructured":"Pinna G, Rasmusson AM (2014) Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder. Front Cell Neurosci 8:256","journal-title":"Front Cell Neurosci"},{"key":"4115_CR60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbr.2010.06.025","volume":"214","author":"RL Pobbe","year":"2010","unstructured":"Pobbe RL, Pearson BL, Defensor EB, Bolivar VJ, Blanchard DC, Blanchard RJ (2010) Expression of social behaviors of C57BL\/6J versus BTBR inbred mouse strains in the visible burrow system. Behav Brain Res 214:443\u2013449","journal-title":"Behav Brain Res"},{"key":"4115_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bbr.2010.08.039","volume":"216","author":"RL Pobbe","year":"2011","unstructured":"Pobbe RL, Defensor EB, Pearson BL, Bolivar VJ, Blanchard DC, Blanchard RJ (2011) General and social anxiety in the BTBR T+ tf\/J mouse strain. Behav Brain Res 216:446\u2013451","journal-title":"Behav Brain Res"},{"key":"4115_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.016","volume":"63","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013) Neuroendocrine aspects of catamenial epilepsy. Horm Behav 63:254\u2013266","journal-title":"Horm Behav"},{"key":"4115_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","volume":"89","author":"DS Reddy","year":"2010","unstructured":"Reddy DS, Rogawski MA (2010) Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res 89:254\u2013260","journal-title":"Epilepsy Res"},{"key":"4115_CR64","doi-asserted-by":"crossref","unstructured":"Reddy DS, Rogawski MA (2012) Neurosteroids\u2014endogenous regulators of seizure susceptibility and role in the treatment of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper\u2019s basic mechanisms of the epilepsies, Bethesda (MD)","DOI":"10.1093\/med\/9780199746545.003.0077"},{"key":"4115_CR65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.104.065268","volume":"310","author":"DS Reddy","year":"2004","unstructured":"Reddy DS, Castaneda DC, O\u2019Malley BW, Rogawski MA (2004) Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 310:230\u2013239","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuropharm.2004.09.002","volume":"48","author":"DS Reddy","year":"2005","unstructured":"Reddy DS, O\u2019Malley BW, Rogawski MA (2005) Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48:14\u201324","journal-title":"Neuropharmacology"},{"key":"4115_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0091-3057(97)00339-0","volume":"59","author":"RJ Rodgers","year":"1998","unstructured":"Rodgers RJ, Johnson NJ (1998) Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 59:221\u2013232","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR68","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF02253596","volume":"106","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology 106:102\u2013110","journal-title":"Psychopharmacology"},{"key":"4115_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00004703-200112000-00008","volume":"22","author":"SJ Rogers","year":"2001","unstructured":"Rogers SJ, Wehner DE, Hagerman R (2001) The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr JDBP 22:409\u2013417","journal-title":"J Dev Behav Pediatr JDBP"},{"key":"4115_CR70","doi-asserted-by":"crossref","unstructured":"Romo-Parra H, Blaesse P, Sosulina L, Pape HC (2015) Neurosteroids increase tonic GABAergic inhibition in the lateral section of the central amygdala in mice. J Neurophysiol: JN 00045 2015","DOI":"10.1152\/jn.00045.2015"},{"key":"4115_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","volume":"2","author":"JL Rubenstein","year":"2003","unstructured":"Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of excitation\/inhibition in key neural systems. Genes Brain Behav 2:255\u2013267","journal-title":"Genes Brain Behav"},{"key":"4115_CR72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-3565(25)12118-6","volume":"275","author":"C Rundfeldt","year":"1995","unstructured":"Rundfeldt C, Wlaz P, Honack D, Loscher W (1995) Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. J Pharmacol Exp Ther 275:693\u2013702","journal-title":"J Pharmacol Exp Ther"},{"key":"4115_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1601-183X.2010.00623.x","volume":"10","author":"ML Scattoni","year":"2011","unstructured":"Scattoni ML, Ricceri L, Crawley JN (2011) Unusual repertoire of vocalizations in adult BTBR T+tf\/J mice during three types of social encounters. Genes Brain Behav 10:44\u201356","journal-title":"Genes Brain Behav"},{"key":"4115_CR74","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/npp.2009.201","volume":"35","author":"JL Silverman","year":"2010","unstructured":"Silverman JL, Tolu SS, Barkan CL, Crawley JN (2010) Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 35:976\u2013989","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"4115_CR75","doi-asserted-by":"crossref","first-page":"131ra51","DOI":"10.1126\/scitranslmed.3003501","volume":"4","author":"JL Silverman","year":"2012","unstructured":"Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN (2012) Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 4:131ra51","journal-title":"Sci Transl Med"},{"key":"4115_CR76","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2012.07.013","volume":"64","author":"JL Silverman","year":"2013","unstructured":"Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN (2013) AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology 64:268\u2013282","journal-title":"Neuropharmacology"},{"key":"4115_CR77","doi-asserted-by":"crossref","unstructured":"Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben H, Baker S, 'Crawley JN (2015) GABA receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol","DOI":"10.1038\/npp.2015.66"},{"key":"4115_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pbb.2015.03.011","volume":"133","author":"T Thompson","year":"2015","unstructured":"Thompson T, Grabowski-Boase L, Tarantino LM (2015) Prototypical anxiolytics do not reduce anxiety-like behavior in the open field in C57BL\/6J mice. Pharmacol Biochem Behav 133:7\u201317","journal-title":"Pharmacol Biochem Behav"},{"key":"4115_CR79","doi-asserted-by":"crossref","unstructured":"Thurman AJ, McDuffie A, Kover ST, Hagerman RJ, Abbeduto L (2015) Autism symptomatology in boys with fragile X syndrome: a cross sectional developmental trajectories comparison with nonsyndromic autism spectrum disorder. J Autism Dev Disord","DOI":"10.1007\/s10803-015-2443-4"},{"issue":"Suppl 3","key":"4115_CR80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","volume":"42","author":"DM Treiman","year":"2001","unstructured":"Treiman DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42(Suppl 3):8\u201312","journal-title":"Epilepsia"},{"key":"4115_CR81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s002130050060","volume":"148","author":"JT Ungard","year":"2000","unstructured":"Ungard JT, Beekman M, Gasior M, Carter RB, Dijkstra D, Witkin JM (2000) Modification of behavioral effects of drugs in mice by neuroactive steroids. Psychopharmacology 148:336\u2013343","journal-title":"Psychopharmacology"},{"key":"4115_CR82","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fendo.2011.00044","volume":"2","author":"M Wang","year":"2011","unstructured":"Wang M (2011) Neurosteroids and GABA-A receptor function. Front Endocrinol 2:44","journal-title":"Front Endocrinol"},{"key":"4115_CR83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02245251","volume":"118","author":"S Wieland","year":"1995","unstructured":"Wieland S, Belluzzi JD, Stein L, Lan NC (1995) Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents. Psychopharmacology 118:65\u201371","journal-title":"Psychopharmacology"},{"key":"4115_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s002130050424","volume":"134","author":"S Wieland","year":"1997","unstructured":"Wieland S, Belluzzi J, Hawkinson JE, Hogenkamp D, Upasani R, Stein L, Wood PL, Gee KW, Lan NC (1997) Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593. Psychopharmacology 134:46\u201354","journal-title":"Psychopharmacology"},{"key":"4115_CR85","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ijdevneu.2007.09.008","volume":"25","author":"M Yang","year":"2007","unstructured":"Yang M, Zhodzishsky V, Crawley JN (2007) Social deficits in BTBR T+tf\/J mice are unchanged by cross-fostering with C57BL\/6J mothers. Int J Dev Neurosci Off J Int Soc Dev Neurosci 25:515\u2013521","journal-title":"Int J Dev Neurosci Off J Int Soc Dev Neurosci"},{"key":"4115_CR86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/aur.163","volume":"4","author":"M Yang","year":"2011","unstructured":"Yang M, Perry K, Weber MD, Katz AM, Crawley JN (2011a) Social peers rescue autism-relevant sociability deficits in adolescent mice. Autism Res Off J Int Soc Autism Res 4:17\u201327","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"4115_CR87","doi-asserted-by":"crossref","unstructured":"Yang M, Silverman JL, Crawley JN (2011b) Automated three-chambered social approach task for mice. Current protocols in neuroscience\/editorial board, Jacqueline N Crawley [et al.] Chapter 8: Unit 8 26","DOI":"10.1002\/0471142301.ns0826s56"},{"key":"4115_CR88","doi-asserted-by":"crossref","unstructured":"Yang M, Loureiro D, Kalikhman D, Crawley JN (2013) Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena. Front Behav Neurosci 7:159","DOI":"10.3389\/fnbeh.2013.00159"},{"key":"4115_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.10.024","volume":"90","author":"WQ Zhang","year":"2015","unstructured":"Zhang WQ, Smolik CM, Barba-Escobedo PA, Gamez M, Sanchez JJ, Javors MA, Daws LC, Gould GG (2015) Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology 90:1\u20138","journal-title":"Neuropharmacology"},{"key":"4115_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.physbeh.2009.05.014","volume":"99","author":"B Zimmerberg","year":"2010","unstructured":"Zimmerberg B, Martinez AR, Skudder CM, Killien EY, Robinson SA, Brunelli SA (2010) Effects of gestational allopregnanolone administration in rats bred for high affective behavior. Physiol Behav 99:212\u2013217","journal-title":"Physiol Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-4115-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4115-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-4115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:12:27Z","timestamp":1748679147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-4115-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["4115"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-4115-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]},"assertion":[{"value":"13 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures were conducted in compliance with the NIH Guidelines for the Care and Use of Laboratory Animals and approved by the UC Davis Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. Hagerman has received funding from the Department of Defense and from Marinus Pharmaceuticals to study ganaxolone in a controlled trial in fragile X syndrome, both with and without autism. Dr. Rogawski is a consultant to Sage Therapeutics. Drs. Kazdoba, Zolkowska, and Crawley declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}